← Research library / Muscle

MGF and PEG-MGF: What the Evidence Actually Shows

PreclinicalNo approval

The short version

  • Mechano growth factor is a splice variant of IGF-1 expressed locally after mechanical muscle damage.
  • The biology is real and interesting. The case for injecting it is not established.
  • PEG-MGF is a pegylated version intended to last longer in circulation.
  • No human trials. Everything circulating is mechanism plus anecdote.
  • No approval.

The biology is genuinely interesting

When muscle is damaged by mechanical loading, the IGF-1 gene is spliced differently, producing a variant with a distinct C-terminal peptide. That variant appears to activate satellite cells, which are the muscle stem cells responsible for repair. It is a locally produced, locally acting signal.

Why the injectable version is a leap

The key word is local. MGF is expressed in the damaged tissue, acts there, and is short lived. Injecting a synthetic version into the bloodstream, or into a muscle, is a fundamentally different proposition from the physiology being cited, and it has not been shown to reproduce it.

PEG-MGF exists to extend circulation time, which arguably moves further from the natural pattern rather than closer to it.

What this will not do

Related

Full library · Safety and sourcing · Reconstitution calculator · The 2026 regulatory picture

Regulatory status current as of the page date. This area is changing quickly and this page is reviewed monthly.